3D Placental Volume in Placenta Accreta

ConditionPlacenta Accreta

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

AgeNot listed

SponsorAssiut University

About this trial

Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

pregnant women with placenta previa

Disqualifiers

congenital anomalies of placenta Placental separation Uterine anomalies

Trial population

All patients with placenta previa from 24 -39 weeks will be counselled to participate in the study. Patients will be enrolled in one of the 2 groups. Group 1, 3D Ultrasound with placental volume and vascular indices will be calculated. Group 2 , 2D ultrasound parameters and color Doppler study will be performed.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

3D Ultrasound
Radiation
3D placental volume and vascular indices
2D ultrasound
Radiation
2D placental criteria of invasion and color Doppler

Treatment groups

38 Participants

are divided into 2 treatment groups

Group A: 3D Ultrasound1 intervention

Group B: 2D ultrasound1 intervention

Trial outcomes

Primary outcomes

Vascular index

3D Vascularization index

Time frame

1 months

Secondary outcomes

2D ultrasound

myometrial thinning (\>1mm),

Time frame

1 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

Apply now